Alligator Bioscience: Valuation, Funding & Investors
Alligator Bioscience is a research-based biotechnology company developing antibody-based pharmaceuticals for cancer treatment. The Company specializes in the development of tumor-directed immunotherapies, in particular agonistic mono- and bispecific antibodies.
Leadership & Board
- Current Number of Employees
- 26
- Current LinkedIn Followers
- 11,400
Latest Estimated Valuation
- Total Amount Raised
- $120M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $120M
- Latest Funding Round
- Investment
Employee Trend
Alligator Bioscience had 26 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Alligator Bioscience had 11,400 followers as of November 16, 2026. The number of followers increased by 11 (0.10%) week-over-week.
Main Enterprise Clients
A snapshot of major enterprise customers that use this private company’s products or services, highlighting its commercial reach and market adoption.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Oct 22, 2025 | Investment | $120.00M | ― |
Similar Companies
A snapshot of private companies similar to Alligator Bioscience, helping you discover and navigate related company profiles.
Related News and Analysis







